Bone-specific alkaline phosphatase - a potential biomarker for skeletal growth assessment

J Orthod. 2018 Mar;45(1):4-10. doi: 10.1080/14653125.2017.1416571. Epub 2017 Dec 27.

Abstract

Objective: The present study was aimed to assess levels of serum Bone-specific alkaline phosphatase (BALP) and serum Insulin-like growth factor-1 (IGF-1) and comparing with cervical vertebral maturation index (CVMI) stages.

Design: Cross-sectional study.

Setting: Maulana Azad Institute of Dental Sciences, New Delhi, India.

Participants: 150 subjects (75 males and 75 females) in the age group of 8-20 years.

Methods: Subjects were divided into six CVMI stages. Enzyme-linked immunosorbant assay was performed for the estimation of serum BALP and serum IGF-1 levels. Mann-Whitney U test was performed to compare mean ranks of serum BALP and serum IGF-1 with different CVMI stages. Spearman correlation between serum BALP and serum IGF-1 was done across 6 CVMI stages.

Results: Peak serum IGF-1 levels were found at CVMI stages 4 and 3 for males and females respectively. Peak levels for serum BALP were found at stage 3 for both genders with significant differences from other stages. A statistically significant correlation was seen between serum IGF-1 and serum BALP from CVMI stages 1 to 3 and 4 to 6 (p < .01).

Conclusions: BALP showed promising results and can be employed as a potential biomarker for the estimation of growth status.

Keywords: Biomarkers; IGF-1; bone-specific alkaline phosphatase; skeletal growth.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaline Phosphatase*
  • Biomarkers
  • Cervical Vertebrae
  • Cross-Sectional Studies
  • Female
  • Humans
  • Insulin-Like Growth Factor I*
  • Male

Substances

  • Biomarkers
  • Insulin-Like Growth Factor I
  • Alkaline Phosphatase